References
- Xue J, Zhong S, Sun B, et al. Lnc-THOR silencing inhibits human glioma cell survival by activating MAGEA6-AMPK signaling. Cell Death & Disease. 2019;10:866.
- Tao C, Luo H, Chen L, et al. Identification of an epithelial-mesenchymal transition related long non-coding RNA (LncRNA) signature in Glioma. Bioengineered. 2021;12(1):4016–4031.
- Zheng D, Chen D, Lin F, et al. LncRNA NNT-AS1 promote glioma cell proliferation and metastases through miR-494-3p/PRMT1 axis. Cell Cycle. 2020;19:1621–1631.
- Clavreul A, Roger E, Pourbaghi-Masouleh M, et al. Development and characterization of sorafenib-loaded lipid nanocapsules for the treatment of glioblastoma. Drug Delivery. 2018;25:1756–1765.
- Hu Y, Kang C, Zhao J, et al. LncRNA PLAC2 down-regulates RPL36 expression and blocks cell cycle progression in glioma through a mechanism involving STAT1. Journal of Cellular and Molecular Medicine. 2018;22:497–510.
- Xiao L, Li X, Mu Z, et al. FTO inhibition enhances the anti-tumor effect of temozolomide by targeting MYC-miR-155/23a cluster-MXI1 feedback circuit in glioma. Cancer Research. 2020;80:3945–3958.
- X Z, H L, F L, et al. LncRNA cancer susceptibility candidate (CASC7) upregulates phosphatase and tensin homolog by downregulating miR-10a to inhibit neuroblastoma cell proliferation. 2020;31:381.
- Death PLJC, Disease, Liang Z-X, Liu H-S, Wang F-W, et al. Correction: lncRNA RPPH1 promotes colorectal cancer metastasis by interacting with TUBB3 and by promoting exosomes-mediated macrophage M2 polarization. 2020;11.
- Fan Y, Sheng W, Meng Y, et al. LncRNA PTENP1 inhibits cervical cancer progression by suppressing miR-106b. Artificial Cells, Nanomedicine, and Biotechnology. 2020;48:393–407.
- Zhang J, Li XY, Hu P, et al. lncRNA NORAD contributes to colorectal cancer progression by Inhibition of miR-202-5p. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 2018;26(9):1411–1418.
- Zhen Q, Gao LN, Wang RF, et al. LncRNA DANCR promotes lung cancer by sequestering miR-216a. Cancer Control. 2018;25:107327481876984.
- He Z, Wang Y, Huang G, et al. The lncRNA UCA1 interacts with miR-182 to modulate glioma proliferation and migration by targeting iASPP. Archives of Biochemistry and Biophysics. 2017;S0003986116305501.
- Zhang H, Wan L, Wei D-L, et al. Highly expressed lncRNA CCND2-AS1 promotes glioma cell proliferation through Wnt/beta-catenin signaling. Biochemical and Biophysical Research Communications. 2017;482:1219–1225
- Xiong Z, Wang L, Wang Q, et al. LncRNA MALAT1/miR-129 axis promotes glioma tumorigenesis by targeting SOX2. J Cell Mol Med. 2018;22(8):3929–3940.
- Tian Y, Zheng Y, Dong X. AGAP2-AS1 serves as an oncogenic lncRNA and prognostic biomarker in glioblastoma multiforme. J Cell Biochem. 2019;120(6):9056–9062.
- Jin XY, Hong W, Oncology DO, et al. Role of microRNA-34a in lung cancer cell apoptosis. 2016.
- Iorio MV, Croce CMJC. microRNA involvement in human cancer. 1126.
- Tomasetti M, Santarelli L, Neuzil J, et al. MicroRNA regulation of cancer metabolism: role in tumour suppression. Mitochondrion. 2014;19:29–38.
- Yao R, Zheng H, Wu L, et al. Therapy. MiRNA-641 inhibits the proliferation, migration, and invasion and induces apoptosis of cervical cancer cells by directly targeting ZEB1. OncoTargets and Therapy. 2018;11:8965–8976.
- Xiong H, Chen R, Liu S, et al. MicroRNA-183 induces epithelial-mesenchymal transition and promotes endometrial cancer cell migration and invasion in by targeting CPEB1. Journal of Cellular Biochemistry. 2018;119.
- Guanlin T, Ruoyang D, Zhaobing T, et al. MiRNALet‐7a mediates prostate cancer PC‐3 cell invasion, migration by inducing epithelial‐mesenchymal transition through CCR7/MAPK pathway. Journal of Cellular Biochemistry. 2018;119:3725–3731.
- Dongyang L, Xuanyu H, Yudi D, et al. PF4V1, an miRNA-875-3p target, suppresses cell proliferation, migration, and invasion in prostate cancer and serves as a potential prognostic biomarker. Cancer Management and Research. 2019;11:2299
- Low SS, Pan Y, Ji D, et al. Smartphone-based portable electrochemical biosensing system for detection of circulating MicroRNA-21 in saliva as a proof-of-concept. Sensors and Actuators B: Chemical. 2020;308:127718.
- Liu XH, Sun M, Nie FQ, et al. Lnc RNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer. Molecular Cancer. 2014;13:92.
- Lv J, Ma L, Chen XL, et al. Downregulation of LncRNAH19 and MiR-675 promotes migration and invasion of human hepatocellular carcinoma cells through AKT/GSK-3β/Cdc25A signaling pathway. 2014;34:363.
- Wang X, Jiang G, Ren W, et al. LncRNA NEAT1 regulates 5-Fu sensitivity, apoptosis and invasion in colorectal cancer through the MiR-150-5p/CPSF4 axis. 2020;13:6373–6383.
- Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods. 2001;25(4):402–408.
- Zhang Y, Zhang Y, Wang S, et al. SP1-induced lncRNA ZFPM2 antisense RNA 1 (ZFPM2-AS1) aggravates glioma progression via the miR-515-5p/Superoxide dismutase 2 (SOD2) axis. Bioengineered. 2021;12(1):2299–2310.
- Zhou D, Lin X, Wang P, et al. Circular RNA circ_0001162 promotes cell proliferation and invasion of glioma via the miR-936/ERBB4 axis. Bioengineered. 2021;12(1):2106–2118.
- Jeong S, Jung S, Park GS, et al. Piperine synergistically enhances the effect of temozolomide against temozolomide-resistant human glioma cell lines. Bioengineered. 2020;11(1):791–800.
- Jie Y, Ye L, Chen H, et al. ELFN1-AS1 accelerates cell proliferation, invasion and migration via regulating miR-497-3p/CLDN4 axis in ovarian cancer. Bioengineered. 2020;11(1):872–882.
- Ren T, Liu C, Hou J, et al. Hsa_circ_0043265 suppresses proliferation, metastasis, EMT and promotes apoptosis in non-small cell lung cancer through miR-25-3p/FOXP2 pathway. Onco Targets Ther. 2020;13:3867–3880.
- Xin Y, Zhang W, Mao C, et al. Therapy. LncRNA LINC01140 inhibits glioma cell migration and invasion via modulation of miR-199a-3p/ZHX1 axis. 2020;13:1833–1844.
- Chen J, Wu Z, YJIJoI Z. Pharmacology. LncRNA SNHG3 promotes cell growth by sponging miR-196a-5p and indicates the poor survival in osteosarcoma. 2019;33.
- Sun Y, Lv B, Pharmakologie X. Knock-down of LncRNA-XIST induced glioma cell death and inhibited tumorigenesis by regulating miR-137/SLC1A5 axis-mediated ROS production. Naunyn-Schmiedeberg’s Archives of Pharmacology. 2020;394(3):557.
- Wu X, Xia T, Cao M, et al. research KJJTic, treatment. LncRNA BANCR promotes pancreatic cancer tumorigenesis via modulating MiR-195-5p/Wnt/β-Catenin signaling pathway. 2019;18:153303381988796.
- Cui L, Nai M, Zhang K, et al. Research. lncRNA WT1-AS inhibits the aggressiveness of cervical cancer cell via regulating p53 expression via sponging miR-330-5p. Cancer Management and Research. 2019;11:651–667.
- Bao X-N, Wang S-W. ence YLJAoM. Downregulated expression of lncRNA TUBA4B predicts unfavorable prognosis and suppresses glioma progression by sponging miR-183 to regulate SMAD4 expression. Archives of Medical Science. 2020;16.
- Zong Z, Song Y, Xue Y, et al. Knockdown of LncRNA SCAMP1 suppressed malignant biological behaviours of glioma cells via modulating miR‐499a‐5p/LMX1A/NLRC5 pathway. 2019;23.
- Ma R, Zhang B-W, Zhang Z-B, et al. LncRNA MALAT1 knockdown inhibits cell migration and invasion by suppressing autophagy through miR-384/GOLM1 axis in glioma. European Review for Medical and Pharmacological Sciences. 2020;24:2601–2615
- Li H, Guo S, Zhang M, et al. LncRNA AGAP2-AS1 accelerates cell proliferation, migration, invasion and EMT process in colorectal cancer via regulating miR-4668-3p/SRSF1 axis. 2020;e3250.
- Gao L, Zhao A, Wang X. Upregulation of lncRNA AGAP2-AS1 is an independent predictor of poor survival in patients with clear cell renal carcinoma. 2020;19:3993–4001.
- Shen S, Li K, Liu Y, et al. Silencing lncRNA AGAP2-AS1 upregulates miR-195-5p to repress migration and invasion of EC cells via the decrease of FOSL1 expression. Molecular Therapy-Nucleic Acids. 2020;20:331–344.
- Zheng Y, Lu S, Xu Y, et al. Long non-coding RNA AGAP2-AS1 promotes the proliferation of glioma cells by sponging miR-15a/b-5p to upregulate the expression of HDGF and activating Wnt/β-catenin signaling pathway. Int J Biol Macromol. 2019;1 28:521–530.
- Zhou RS, Zhang EX, Sun QF, et al. Integrated analysis of lncRNA-miRNA-mRNA ceRNA network in squamous cell carcinoma of tongue. BMC Cancer. 2019;19(1):779.
- Yang G, Xiong G, Cao Z, et al. miR-497 expression, function and clinical application in cancer. Oncotarget. 2016;7(34):55900–55911.
- Tian Z, Yan M, Li S, et al. miR-497 inhibits tumor growth and migration of osteosarcoma by targeting plexinA4 and CDK6. Neoplasma. 2020;67(5):1122–1130.
- Li C, Wang S, Yang C. Long non-coding RNA DLX6-AS1 regulates neuroblastoma progression by targeting YAP1 via miR-497-5p. 252(117657):2020.
- Cheng L, Xing Z, Zhang P, et al. Long non-coding RNA LINC00662 promotes proliferation and migration of breast cancer cells via regulating the miR-497-5p/EglN2 axis. Acta Biochim Pol. 2020;67:229–237.
- Lu J, Li D, Zeng Y, et al. IDH1 mutation promotes proliferation and migration of glioma cells via EMT induction. J BUON. 2019;24:2458–2464.
- Wang ZS, Shen Y, Li X, et al. Significance and prognostic value of Gli-1 and Snail/E-cadherin expression in progressive gastric cancer. Tumour Biol. 2014;35(2):1357–1363.
- Azizi P, Mazhari S, Tokhanbigli S, et al. Paracrine signals of mesenchymal stem cells induce epithelial to mesenchymal transition in gastric cancer cells. Gastroenterol Hepatol Bed Bench. 2019;12:S51–s7.
- Simi AK, Anlaş AA, Stallings-Mann M, et al. A soft microenvironment protects from failure of midbody abscission and multinucleation downstream of the EMT-promoting transcription factor snail. Cancer Res. 2018;78(9):2277–2289.
- Ning W, Qiu Z, Ji X, et al. The prognostic value of EMT in glioma and its role in the glioma immune microenvironment. J Mol Neurosci. 2020;70(10):1501–1511.